Twenty Years of Therapeutic Leukocytapheresis in Newly Diagnosed Acute Myeloid Leukemia: Insights From A Single Center
{{output}}
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy, and 5%-20% of newly diagnosed patients present with hyperleukocytosis (HL). HL, most often defined as WBC > 100 000/μL, is a hematologic emergency associated with severe complications, ea... ...
